Taha Almarsoomi, Derya Osmaniye, Begüm Nurpelin Sağlık, Serkan Levent, Usman Ghani, Yusuf Özkay, Zafer Asım Kaplancıklı
{"title":"Synthesis of new compounds bearing methyl sulfonyl pharmacophore as selective COX-2 inhibitor","authors":"Taha Almarsoomi, Derya Osmaniye, Begüm Nurpelin Sağlık, Serkan Levent, Usman Ghani, Yusuf Özkay, Zafer Asım Kaplancıklı","doi":"10.1002/jmr.3025","DOIUrl":null,"url":null,"abstract":"<p>Cyclooxygenase, also known as prostaglandin H2 synthase (PGH2), is one of the most important enzymes in pharmacology because inhibition of COX is the mechanism of action of most nonsteroidal anti-inflammatory drugs. In this study, ten thiazole derivative compounds had synthesized. The analysis of the obtained compounds was performed by <sup>1</sup>H NMR and <sup>13</sup>C NMR methods. By this method, the obtained compounds could be elucidated. The inhibitory effect of the obtained compounds on cyclooxygenase (COX) enzymes was investigated. The encoded compounds <b>5a</b>, <b>5b</b>, and <b>5c</b> were found to be the most potent compared to the reference compounds ibuprofen (IC<sub>50</sub> = 5.589 ± 0.278 μM), celecoxib (IC<sub>50</sub> = 0.132 ± 0.004 μM), and nimesulide (IC<sub>50</sub> = 1.692 ± 0.077 μM)against COX-2 isoenzyme. The inhibitory activity of <b>5a</b>, <b>5b</b>, and <b>5c</b> is approximate, but the <b>5a</b> derivative proved to be the most active in the series with an IC<sub>50</sub> value of 0.180 ± 0.002 μM. The most potent COXs inhibitor was <b>5a</b>, which was further investigated for its potential binding mode by a molecular docking study. Compound <b>5a</b> was found to be localized at the active site of the enzyme, like celecoxib, which has a remarkable effect on COXs enzymes.</p>","PeriodicalId":16531,"journal":{"name":"Journal of Molecular Recognition","volume":"36 7","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Recognition","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jmr.3025","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Cyclooxygenase, also known as prostaglandin H2 synthase (PGH2), is one of the most important enzymes in pharmacology because inhibition of COX is the mechanism of action of most nonsteroidal anti-inflammatory drugs. In this study, ten thiazole derivative compounds had synthesized. The analysis of the obtained compounds was performed by 1H NMR and 13C NMR methods. By this method, the obtained compounds could be elucidated. The inhibitory effect of the obtained compounds on cyclooxygenase (COX) enzymes was investigated. The encoded compounds 5a, 5b, and 5c were found to be the most potent compared to the reference compounds ibuprofen (IC50 = 5.589 ± 0.278 μM), celecoxib (IC50 = 0.132 ± 0.004 μM), and nimesulide (IC50 = 1.692 ± 0.077 μM)against COX-2 isoenzyme. The inhibitory activity of 5a, 5b, and 5c is approximate, but the 5a derivative proved to be the most active in the series with an IC50 value of 0.180 ± 0.002 μM. The most potent COXs inhibitor was 5a, which was further investigated for its potential binding mode by a molecular docking study. Compound 5a was found to be localized at the active site of the enzyme, like celecoxib, which has a remarkable effect on COXs enzymes.
期刊介绍:
Journal of Molecular Recognition (JMR) publishes original research papers and reviews describing substantial advances in our understanding of molecular recognition phenomena in life sciences, covering all aspects from biochemistry, molecular biology, medicine, and biophysics. The research may employ experimental, theoretical and/or computational approaches.
The focus of the journal is on recognition phenomena involving biomolecules and their biological / biochemical partners rather than on the recognition of metal ions or inorganic compounds. Molecular recognition involves non-covalent specific interactions between two or more biological molecules, molecular aggregates, cellular modules or organelles, as exemplified by receptor-ligand, antigen-antibody, nucleic acid-protein, sugar-lectin, to mention just a few of the possible interactions. The journal invites manuscripts that aim to achieve a complete description of molecular recognition mechanisms between well-characterized biomolecules in terms of structure, dynamics and biological activity. Such studies may help the future development of new drugs and vaccines, although the experimental testing of new drugs and vaccines falls outside the scope of the journal. Manuscripts that describe the application of standard approaches and techniques to design or model new molecular entities or to describe interactions between biomolecules, but do not provide new insights into molecular recognition processes will not be considered. Similarly, manuscripts involving biomolecules uncharacterized at the sequence level (e.g. calf thymus DNA) will not be considered.